This is the podcast site for iForumRx.org - a community of ambulatory care pharmacy specialists and others interested in the evidence regarding drug therapy and patient management.
All content for iForumRx.org is the property of University of Mississippi School of Pharmacy and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
This is the podcast site for iForumRx.org - a community of ambulatory care pharmacy specialists and others interested in the evidence regarding drug therapy and patient management.
Ascending the SUMMIT: Tirzepatide’s Breakthrough in HFpEF
iForumRx.org
17 minutes
3 months ago
Ascending the SUMMIT: Tirzepatide’s Breakthrough in HFpEF
Heart failure with preserved ejection fraction (HFpEF) poses a significant challenge because of its heterogeneous nature and the scarcity of therapies that meaningfully alter its course. The SUMMIT study evaluated the impact of tirzepatide on symptoms and mortality in people with HFpEF and obesity.
Guests: Jennifer N. Clements, Pharm.D., FCCP, FADCES, BCPS, BCACP, BC-ADM, CDCES and Dawn C. Fuke, Pharm.D., BCPS, BCACP
Music by Good Talk
iForumRx.org
This is the podcast site for iForumRx.org - a community of ambulatory care pharmacy specialists and others interested in the evidence regarding drug therapy and patient management.
